Comparative Efficacy and Safety of Fenoverine

Clinical trial NCT01507922 · COMPLETED

Trial details

NCT number: NCT01507922
Sponsor: Bukwang Pharmaceutical
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2011-12-01
Primary completion: 2013-03-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.